Efficacy of Sativex® on Pain, Spasticity, and Disability in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis. (PubMed, Pharmacol Res) - May 18, 2026 - "In addition, a modest but statistically significant improvement in disability, assessed by Expanded Disability Status Scale (EDSS), was detected (SMC: -0.17, 95% CI -0.28 to -0.07, p = 0.0015). Overall, evidence suggests that Sativex may represent an effective therapeutic option for the management of pain and spasticity in patients with MS, with potential benefits for functional disability."
Journal • Retrospective data • Review • CNS Disorders • Immunology • Movement Disorders • Multiple Sclerosis • Neuralgia • Pain
|
|
Carolina Muscoli; Chantalle Moulton; Ennio Tasciotti; Jessica Maiuolo; Lucia Carmela Passacatini; Rosamaria Caminiti; Sabina Pulone; Sara Ilari; Saverio Nucera; Stefania Proietti; Valeria Mazza; Vincenzo Mollace
|